Fabry disease: A morphologic study of 11 cases

Modern Pathology

Volumn 19, Issue 10, 2006, Pages 1295-1301

  Fischer, Edgar G ^a,b   Moore, Michael J ^a   Lager, Donna J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha galactosidase A; Fabry disease; Glycosphingolipidosis; Kidney biopsy; Myelin like inclusions

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FABRY DISEASE; FEMALE; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; NEPHROTIC SYNDROME; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA;

ADOLESCENT; ADULT; BIOPSY; FABRY DISEASE; FEMALE; GLOMERULAR BASEMENT MEMBRANE; HUMANS; INCLUSION BODIES; KIDNEY; MALE; PODOCYTES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 33748881819     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800634     Document Type: Article

References (25)

1. Cohen AH, Adler SG. Nail-patella syndrome (osteo-onychodysplasia), lipodystrophy, Fabry's disease (angiokeratoma corporis diffusum universale), and familial lecithin-cholesterol acyltransferase deficiency. In: Tisher CC, Brenner BM (eds). Renal Pathology, 2nd edn. Lippincott Company: Philadelphia, 1994, pp 1267-1289.
2. Bernstein J, Churg J. Heritable metabolic diseases. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds). Heptinstall's Pathology of the Kidney, 5th edn. Lippincott-Raven Publishers: Philadelphia, 1998, pp 1287-1320.
3. Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine 2002;81:122-138.
4. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138:338-346.
5. Nakao S, Kodama C, Takenaka T, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a 'renal variant'. Kidney Int 2003;64: 801-807.
6. Schiffmann R, Kopp JB, Austin III HA, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001;285:2743-2749.
7. Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease. N Engl J Med 2001;345:9-16.
8. Desnick RJ, Banikazemi M, Wasserstein M. Enzyme replacement therapy for Fabry disease, an inherited nephropathy. Clin Nephrol 2002;57:1-8.
9. Fabry J. Ein Beitrag zur Kenntnis der Purpura haemorrhagica nodularis (Purpura haemorrhagica Hebrae). Arch Dermatol Syphilol 1898;43:187.
10. Anderson W. A case of angiokeratoma. Br J Dermatol 1898;10:113.
11. Sessa A, Toson A, Nebuloni M, et al. Renal ultrastructural findings in Anderson-Fabry disease. J Nephrol 2002;15:109-112.
12. Faraggiana T, Churg J, Grishman E, et al. Light- and electron-microscopic histochemistry of Fabry's disease. Am J Pathol 1981;103:247-262.
13. Farge D, Nadler S, Wolfe LS, et al. Diagnostic value of kidney biopsy in heterozygous Fabry's disease. Arch Pathol Lab Med 1985;109:85-88.
14. Popli S, Molnar ZV, Leehey DJ, et al. Involvement of renal allograft by Fabry's disease. Am J Nephrol 1987; 7:316-318.
15. Gubler MC, Lenoir G, Grunfeld JP, et al. Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int 1978;13: 223-235.
16. Alroy J, Sabnis S, Kopp JB. Renal pathology in Fabry disease. J Am Soc Nephrol 2002;13(Suppl 2): S134-S138.
17. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001;38:769-775.
18. Rosenmann E, Kobrin I, Cohen T. Kidney involvement in systemic lupus erythematosus and Fabry's disease. Nephron 1983;34:180-184.
19. Rahman P, Gladman DD, Wither J, et al. Coexistence of Fabry's disease and systemic lupus erythematosus. Clin Exp Rheumatol 1998;16:475-478.
20. Yoshida A, Morozumi K, Takeda A, et al. Fabry-like laminated myelin body associated with IgA nephropathy. Nippon Jinzo Gakkai Shi 1994;36:1303-1307.
21. Kawamura O, Sakuraba H, Itoh K, et al. Subclinical Fabry's disease occurring in the context of IgA nephropathy. Clin Nephrol 1997;47:71-75.
22. Singh HK, Nickeleit V, Kriegsmann J, et al. Coexistence of Fabry's disease and necrotizing and crescentic glomerulonephritis. Clin Nephrol 2001;55:73-79.
23. Shimazu K, Tomiyoshi Y, Aoki S, et al. Crescentic glomerulonephritis in a patient with heterozygous Fabry's disease. Nephron 2002;92:456-458.
24. Muller-Hocker J, Schmid H, Weiss M, et al. Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease: case report and review qof the literature. Hum Pathol 2003;34:285-289.
25. Albay D, Adler SG, Philipose J, et al. Chloroquine-induced lipidosis mimicking Fabry disease. Mod Pathol 2005;18:733-738.